Cargando…
Aβ modulates actin cytoskeleton via SHIP2-mediated phosphoinositide metabolism
Emerging evidences suggest that phospholipid metabolism is altered in Alzheimer’s disease (AD), but molecular mechanisms on how this affects neurodegeneration in AD is poorly understood. SHIP2 is a phosphoinositide-metabolizing enzyme, which dephosphorylates PI(3,4,5)P(3) resulting to PI(3,4)P(2), a...
Autores principales: | Lee, Hae Nim, Sim, Kyoung Mi, Kim, Hyunbin, Ju, Jeongmin, Pae, Ae Nim, Park, Jae-Bong, Ryu, Hoon, Seong, Jihye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820556/ https://www.ncbi.nlm.nih.gov/pubmed/31664099 http://dx.doi.org/10.1038/s41598-019-51914-2 |
Ejemplares similares
Ejemplares similares
-
Genetically Encoded Biosensors Based on Fluorescent Proteins
por: Kim, Hyunbin, et al.
Publicado: (2021) -
Phosphoinositide 3-Kinase regulates glycolysis through mobilization of Aldolase A from the actin cytoskeleton
por: Hu, Hai, et al.
Publicado: (2014) -
Phosphoinositide 3-Kinase C2β Regulates RhoA and the Actin Cytoskeleton through an Interaction with Dbl
por: Błajecka, Karolina, et al.
Publicado: (2012) -
Mitochondrial dysfunction and Alzheimer’s disease: prospects for therapeutic intervention
por: Lim, Ji Woong, et al.
Publicado: (2020) -
9-[(E)-2-(2-Methoxyphenyl)ethenyl]-3,4,5,6,7,9-hexahydro-2H-xanthene-1,8-dione
por: Cha, Joo Hwan, et al.
Publicado: (2012)